Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · Indiana

Point Biopharma USA Inc

Indianapolis, IN · ~44 workers · 2 years of OSHA Injury Tracking Application data.

C
Average Safety Record
0.0
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Point Biopharma USA Inc runs at 0% of its industry's injury rate - about level with the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade C.

Point Biopharma USA Inc: 0.0 TCR = 0% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 2y Form 300A (see methodology below)

Point Biopharma USA Inc safety composite

Point Biopharma USA Inc scores strongest on total case rate (tcr) (safer than 100% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

B

82/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
A 0 per 100 workers

Safer than 100% of industry peers

DART rate
B 0 per 100 workers

Safer than 83% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Point Biopharma USA Inc held a steady TCR band

Point Biopharma USA Inc's TCR held near 0.0 from 0.0 in 2021 to 0.0 in 2022. Peak filing year was 2021 at 0.0 TCR.

2021=0.0 · 2022=0.0

OSHA ITA Form 300A scorecard

Establishment book 325412 · Indianapolis, IN AT/BELOW-IND · SMALL

Grade C · TCR 0.0 · 0% of ind

  • DART 0.0 DART
  • RANK #0/24
  • PHOTO Astellas Pharma Glob…
  • BOOK 2y book
  • INJ 0 inj
  • SIZE ~44 FTE

Nearest TCR peer: Astellas Pharma Global Development (0.0 TCR gap)

Read with this employer → · Industry book → · Indiana employers → · Look up another →

Point Biopharma USA Inc in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Point Biopharma USA Inc averages 0.0 TCR (0% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Point Biopharma USA Inc TCR series: 2021=0 · 2022=0 · BLS 3.3

Where Point Biopharma USA Inc falls in its industry

855 Pharmaceutical preparations (e establishments

Safer than 100% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to Indiana alone (the establishments it most directly competes with for workers and contracts): ranked #0 safest of 24 Pharmaceutical preparations (e employers in Indiana.

Point Biopharma USA Inc (44 employees, TCR 0.0) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 051015 Average employees Total Case Rate Point Biopharma USA Inc
Point Biopharma USA Inc (44 employees, TCR 0.0) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6

Point Biopharma USA Inc has fewer employees than the Pharmaceutical preparations (e.g., capsu median and a lower injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2022 0.0 0.0 0 0 0
2021 0.0 0.0 0 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325412 · IN · Indianapolis

855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 12,750 rated employers in Indiana with headcount on file · 2,074 employers in Indianapolis, IN · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Astellas Pharma Global Development 0.0 TCR
NAICS-TCR Astellas US LLC 0.1 TCR
NAICS-TCR Mylan Pharmaceutical - Greenbag Road 0.1 TCR
NAICS-TCR Janssen Ortho LLC-Gurabo 0.1 TCR
STATE-SIZE 2307-Whitestown, IN (Monsanto Co.) 44 FTE
STATE-SIZE RushShelby Energy 44 FTE
STATE-SIZE OCM Engineering, LLC 44 FTE
STATE-SIZE Michels Power Inc-IN-Rolling Prairie 44 FTE
CITY-NEAR Indiana University Health, Inc 7,874 FTE
CITY-NEAR Methodist Hospital 6,862 FTE
CITY-NEAR Eli Lilly - Lilly Corp Center 6,482 FTE
CITY-NEAR Lilly Technology Center 6,472 FTE
NAT-TCR Raleigh Managed Services 0.0 TCR
NAT-TCR California Department of Transportation Facility 128 0.0 TCR
NAT-TCR Integration Appliance Inc. 0.0 TCR
NAT-TCR Airborn Inc. Addison 0.0 TCR
NAT-SIZE Interscapes, Inc. 44 FTE
NAT-SIZE Tidewater Transit-Wilmington 44 FTE
NAT-SIZE Esi Contracting Corp. 44 FTE
NAT-SIZE Office Interiors of Virginia, Inc. 44 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2022, 2021. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details.